CSIMarket Company Name, Ticker, Suppliers, else..


Arcadia Biosciences Inc   (NASDAQ: RKDA)
Other Ticker:  
 

Arcadia Biosciences Inc

RKDA's Fundamental analysis



Arcadia Biosciences Inc 's sales fell by -5.98 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 3244

Agricultural Production industry recorded deterioration of revenues by -12.22 %

Arcadia Biosciences Inc 's net income grew by 29.71 % in II. Quarter 2024 year on year, above company average,

• More on RKDA's Growth


Arcadia Biosciences Inc
realized a net loss in trailing twelve months.

Arcadia Biosciences Inc realized cash reduction of $ -11.11 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
10.1
PE TTM    
Company's Price to Sales ratio is at 1.31.
Agricultural Production industry's Price to Sales ratio is at 0.51.


• More on RKDA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 172,172
 Net Income/Employee (TTM) $ -233,862
 Receivable Turnover (TTM) 8.26
 Tangible Book Value (Per Share $) 8.46

Arcadia Biosciences Inc
realized net loss in trailing twelve months.

Arcadia Biosciences Inc realized cash outflow of $ -11.11per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
10.1
PE TTM    
Company's Price to Sales ratio is at 1.31.
Agricultural Production industry's Price to Sales ratio is at 0.51.

Arcadia Biosciences Inc Price to Book Ratio is at 0.57 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01

• More on RKDA's Valuation

•  Market Capitalization (Millions $) 7
•  Shares Outstanding (Millions) 1
•  Employees 29
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) -7
•  Cash Flow (TTM) (Millions $) -15
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 172,172
•  Net Income/Employee(TTM) $ -233,862
•  Receivable Turnover Ratio (TTM) 8.26
•  Tangible Book Value (Per Share $) 8.46

•  Market Capitalization (Millions $) 7
•  Shares Outstanding (Millions) 1
•  Employees 29
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) -7
•  Cash Flow (TTM) (Millions $) -15
•  Capital Exp. (TTM) (Millions $) 0


    RKDA's Profitability Comparisons
Arcadia Biosciences Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 151.61 %.

Arcadia Biosciences Inc net profit margin of 81.24 % is currently ranking no. 1 in Agricultural Production industry, ranking no. 3 in Consumer Non Cyclical sector and number 93 in S&P 500.


Profitability by Segment
Total 81.24 %



  Ratio
•   Capital Ratio (MRQ) 4.61
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.49
•  Asset Turnover Ratio (TTM) 0.28
•  Inventory Turnover Ratio (TTM) 1.59



Arcadia Biosciences Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 151.61 %.

Arcadia Biosciences Inc net profit margin of 81.24 % is currently ranking no. 1 in Agricultural Production industry, ranking no. 3 in Consumer Non Cyclical sector and number 93 in S&P 500.

• More on RKDA's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com